GENFIT Announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASH

NEXT STORY
Genmab Announces Appointment of Marisol Peron as Head of Communications and Investor Relations
PREV STORY
ASLAN Pharmaceuticals Signs New Agreement With Biogenetics for Commercialisation of ASLAN003 in South Korea
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HON. PATRICK J. MURPHY TO CHAIR CERNER GOVERNMENT ADVISORY BOARD TO HELP IMPROVE VETERAN CARE

author_avatar
NASDAQ Market News

Albireo Announces FDA Approval of Bylvay™ (odevixibat), the First Drug Treatment for Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

author_avatar
NASDAQ Market News

Global Infusion Pump Market (2021 to 2026) – High Growth Opportunities in Emerging Countries

author_avatar
NASDAQ Market News